CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 43(2): 113793, 2024 Feb 27.
Article
in En
| MEDLINE
| ID: mdl-38324452
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Screening_studies
Language:
En
Journal:
Cell Rep
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos